These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


111 related items for PubMed ID: 5497287

  • 1. Analysis of a case of mutagen specificity in Neurospora crassa. 3. Fractionated treatment with diepoxybutane (DEB).
    Auerbach C, Ramsay D.
    Mol Gen Genet; 1970; 109(4):285-91. PubMed ID: 5497287
    [No Abstract] [Full Text] [Related]

  • 2. Analysis of a case of mutagen specificity in Neurospora crassa. II. Interaction between treatments with diepoxybutane (DEB) and ultraviolet light.
    Auerbach C, Ramsay D.
    Mol Gen Genet; 1970; 109(1):1-17. PubMed ID: 5488083
    [No Abstract] [Full Text] [Related]

  • 3. Mutagen specificity in Neurospora crassa.
    De Serres FJ, Brockman HE, Barnett WE, Kolmark HG.
    Mutat Res; 1971 Jun; 12(2):129-42. PubMed ID: 5094801
    [No Abstract] [Full Text] [Related]

  • 4. Mutagen specificity at the ad-3A and inositol loci in Neurospora crassa.
    Allison M.
    Mutat Res; 1969 Jun; 7(2):141-54. PubMed ID: 5796512
    [No Abstract] [Full Text] [Related]

  • 5. Analysis of a case of mutagen specificity in Neurospora crassa. I. Dose-response curves.
    Auerbach C, Ramsay D.
    Mol Gen Genet; 1968 Jun; 103(1):72-104. PubMed ID: 5713537
    [No Abstract] [Full Text] [Related]

  • 6. The manipulation of mutation-induction kinetics in Neurospora crassa.
    Kilbey BJ.
    Mol Gen Genet; 1973 Jun; 123(1):73-6. PubMed ID: 4726377
    [No Abstract] [Full Text] [Related]

  • 7. Investigations into a reversal of diepoxybutane specificity in Neurospora crassa.
    Paterson HF.
    Mutat Res; 1974 Dec; 25(3):411-3. PubMed ID: 4280014
    [No Abstract] [Full Text] [Related]

  • 8. Mutagenicity of chemical carcinogens in Neurospora crassa.
    Ong TM, De Serres FJ.
    Cancer Res; 1972 Sep; 32(9):1890-3. PubMed ID: 4264527
    [No Abstract] [Full Text] [Related]

  • 9. Kinetic studies of mutation induction by epoxides in Neurospora crassa.
    Kolmark HG, Kilbey BJ.
    Mol Gen Genet; 1968 Sep; 101(2):89-98. PubMed ID: 5683008
    [No Abstract] [Full Text] [Related]

  • 10. An effect of genetic background on dose-response curves in Neurospora crassa.
    Allison MJ.
    Mutat Res; 1969 Sep; 7(3):297-306. PubMed ID: 5807325
    [No Abstract] [Full Text] [Related]

  • 11. Analysis of a case of mutagen specificity in Neurospora crassa. IV. Interactions between UV and three chemical mutagens.
    Auerbach C, Ramsay D.
    Mol Gen Genet; 1972 Sep; 117(1):1-13. PubMed ID: 4262635
    [No Abstract] [Full Text] [Related]

  • 12. The stabilisation of a transient mutagen-sensitive state in Neurospora by the protein synthesis inhibitor actidione.
    Kilbey BJ.
    Mol Gen Genet; 1973 Sep; 123(1):67-72. PubMed ID: 4726376
    [No Abstract] [Full Text] [Related]

  • 13. Photoreactivation of mutational damage produced by the interaction between DEB and UV in Neurospora.
    Rannug JU.
    Mol Gen Genet; 1971 Sep; 111(2):194-6. PubMed ID: 5564469
    [No Abstract] [Full Text] [Related]

  • 14. The analysis of a dose-rate effect found with a mutagenic chemical.
    Kilbey BJ.
    Mutat Res; 1974 Aug; 26(4):249-56. PubMed ID: 4854648
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The problem of viability estimates in tests for reverse mutations.
    Auerbach C, Ramsay D.
    Mutat Res; 1971 Apr; 11(4):353-60. PubMed ID: 5111491
    [No Abstract] [Full Text] [Related]

  • 19. Mutagenic activities of aflatoxin B 1 and G 1 in Neurospora crassa.
    Ong TM.
    Mol Gen Genet; 1971 Apr; 111(2):159-70. PubMed ID: 5564467
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 6.